Published date: 14 June 2022

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 9 December 2021, 12pm

Contract summary

Industry

  • Mobile telephones - 32250000

Location of contract

England

Value of contract

£100,000

Procurement reference

NCL001-DN584175-98052629

Published date

14 June 2022

Closing date

9 December 2021

Closing time

12pm

Contract start date

5 April 2022

Contract end date

4 April 2023

Contract type

Supply contract

Procedure type

Other

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No


Description

We are seeking to engage with a suitable vendor to facilitate the procurement of 390 smart devices which will support a key clinical study at Newcastle University - IDEA-FAST.

The IDEA-FAST project is a five-and-a-half-year project focused on digital endpoints in neurodegenerative and immune-mediated diseases which commenced November 2019 and is ran by a consortium of 46 partners across 15 countries in Europe, including Newcastle University.

The project has attracted funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853981. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and EFPIA and PARKINSON'S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.

For Newcastle University's specific clinical study under this project, 2000 participants will be using a handful of wearable sensors for four individual weeks across a period of 6 months. During this period of using these sensors, a smart device is required to collect the data from the sensors, as well as prompt and collect patient-reported outcomes (PRO).

Based upon the technical specification outlined within Section 3, 1800 out of the 2000 participants of the clinical IDEA-FAST study are diagnosed with Neurodegenerative Disorders (NDD) or Immuno-Mediated Inflammatory Disorders (IMID), such as Parkinson's disease (PD), Huntington's Disease (HD) inflammatory bowel disease (IBD), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (PSS).

Taking this into consideration, it is critical that we ensure the usability and user experience of the devices is acceptable, to ensure proper usage, and reduce any potential frustration. This is of extra importance with the elderly within this population. Without exact technical specifics, we can derive design features of the required phone based on prior experience in the Feasibility Study, and the clinical, design, and software expertise within the project.

The output of this sourcing event will enable the University to provide the required devices to deliver the clinical study, ensuring consistency in approach and technical specification.
Out of Scope - Devices that utilise an IOS operating system are deemed as out of scope or devices that are defined as a tablet.


Award information

Awarded date

4 April 2022

Contract start date

5 April 2022

Contract end date

4 April 2023

Total value of contract

£79,415

This contract was awarded to 1 supplier.

Insight Direct UK

Address

The Atrium, 1 Harefield Road, Uxbridge, Middlesex, UB8 1PH

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No


About the buyer

Contact name

Emma Barksby

Address

Newcastle University
Procurement Services, Kingsgate
Newcastle
NE1 7RU
England

Telephone

+44 1912086298

Email

emma.barksby@ncl.ac.uk

Website

https://www.ncl.ac.uk